跳至主要内容
临床试验/CTRI/2024/04/065928
CTRI/2024/04/065928尚未招募Unknown

Prospective Randomized Controlled Trial to Assess the Comparative Efficacy of Midodrine and Tolvaptan Combination Versus Midodrine Therapy in Refractory Ascites in Cirrhotic Patients with Hyponatremia with blinded endpoint assessment.

Amrita School of pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed refractory ascites patients as per the AASLD and EASL guidelines.
  • Definite history of cirrhosis with hyponatremia.
  • Consenting to follow-up.
  • CHILD PUGH - B/C cirrhosis.

排除标准

  • AKI (S. creatinine 1.5mg/dL) and kidney problems.
  • High risk varices.
  • Cerebrovascular accidents within 30 days before the study medication.
  • Acute symptomatic hyponatremia and pseudohyponatremia
  • Hypothyroidism.
  • Cerebrovascular accidents.
  • Multiple strokes.

研究者

发起方
Amrita School of pharmacy

相似试验

comparison of efficacy between tolvaptan and... | 临床试验